ZUMERLE, SARA

ZUMERLE, SARA  

Dipartimento di Scienze del Farmaco - DSF  

Mostra records
Risultati 1 - 20 di 22 (tempo di esecuzione: 0.041 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Identification of novel therapeutic approaches to selectively target senescent cells in prostate cancer In corso di stampa Bressan SilviaZumerle SaraMontopoli MonicaAlimonti Andrea + - - Identification of novel therapeutic approaches to selectively target senescent cells in prostate cancer.
CK2β-regulated signaling controls B cell differentiation and function 2023 Quotti Tubi L.Mandato E.Canovas Nunes S.Arjomand A.Zaffino F.Manni S.Casellato A.Macaccaro P.Vitulo N.Zumerle S.Viola A.Valle G.Pizzi M.Dei Tos A. P.Trentin L.Semenzato G.Piazza F. + FRONTIERS IN IMMUNOLOGY - -
Epiregulation of the SASP makes good neighbors 2021 Desbats, Maria AndreaZumerle, SaraAlimonti, Andrea NATURE AGING - -
Identification of novel therapeutic approaches to selectively target senescent cells in prostate cancer 2021 Zumerle SaraMontopoli MonicaAlimonti Andrea + - - Pharmadvance
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532) 2020 Montopoli, MZumerle, SVettor, RRugge, MZorzi, MRagazzi, EAlimonti, A + ANNALS OF ONCOLOGY - -
Dendritic cell-derived hepcidin sequesters iron from the microbiota to promote mucosal healing 2020 Zumerle S. + SCIENCE - -
Genetic and hormonal influence on SARS-CoV-2-infection susceptibility: Re: The potential influence of human Y-chromosome haplogroup on COVID-19 prevalence and mortality 2020 Montopoli M.Zumerle S.Rugge M.Alimonti A. ANNALS OF ONCOLOGY - -
Identification of novel therapeutic targets to selectively eliminate senescent cells in prostate cancer. 2020 Bressan SilviaZumerle SaraMontopoli MonicaAlimonti Andrea + - - Identification of novel therapeutic targets to selectively eliminate senescent cells in prostate cancer.
In and out from senescence 2020 Zumerle S.Alimonti A. NATURE CELL BIOLOGY - -
Reply to the Letter to the Editor “Androgen deprivation therapy may constitute a more effective prophylactic than therapeutic strategy in COVID-19 patients” by N. Bennani and I. M. Bennani-Baiti 2020 Zumerle S.Montopoli M.Rugge M.Alimonti A. ANNALS OF ONCOLOGY - -
The bladder epicheck test as a non-invasive tool based on the identification of DNA methylation in bladder cancer cells in the urine: A review of published evidence 2020 Righetto M.Zumerle S.Montopoli M.Zattoni F. + INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - -
Cancer immunotherapy 2019 Sara ZumerleAndrea Alimonti - - Revolutionary therapies for cancer
Generation and validation of in vitro models to study senescence 2019 S. BressanS. ZumerleM. SaponaroM. MontopoliA. Alimonti - - Generation and validation of in vitro models to study senescence
Genomic subtypes of bladder cancer with distinct methylation profiles could be better identified by the Bladder EpiCheck test as compared to cystoscopy/urine cytology 2019 Zumerle, S.Barcaro, F.Saponaro, M.Montopoli, M.Ragazzi, E.Pagano, F. + EUROPEAN UROLOGY. SUPPLEMENTS - European Urology Supplements
Intercellular Calcium Signaling Induced by ATP Potentiates Macrophage Phagocytosis 2019 Zumerle, SaraCalì, BiancaMunari, FabioAngioni, RobertaMolon, BarbaraViola, Antonella + CELL REPORTS - -
Membrane rafts in T cell activation: A spotlight on CD28 costimulation 2017 ZUMERLE, SARAMolon, BarbaraViola, Antonella FRONTIERS IN IMMUNOLOGY - -
Pulmonary iron homeostasis in hepcidin knockout mice 2017 Zumerle, Sara + FRONTIERS IN PHYSIOLOGY - -
Hepcidin antagonists for use in the treatment of inflammation 2015 Sara Zumerle + - - -
Investigating the real role of HIF-1 and HIF-2 in iron recycling by macrophages 2014 Zumerle, Sara + HAEMATOLOGICA - -
Targeted disruption of hepcidin in the liver recapitulates the hemochromatotic phenotype 2014 Zumerle, Sara + BLOOD - -